Lipocine Inc.LPCNNASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
+51.0%/yr
vs -10.8%/yr prior
Acceleration
+61.8pp
Accelerating
Percentile
P77
Within normal range
vs 3Y Ago
3.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 25.63% |
| Q3 2025 | -44.48% |
| Q2 2025 | -18.28% |
| Q1 2025 | -204.64% |
| Q4 2024 | 180.32% |
| Q3 2024 | 27.69% |
| Q2 2024 | -187.34% |
| Q1 2024 | 253.95% |
| Q4 2023 | 65.69% |
| Q3 2023 | -87.42% |
| Q2 2023 | 8.31% |
| Q1 2023 | -73.56% |
| Q4 2022 | 7.44% |
| Q3 2022 | 8.46% |
| Q2 2022 | 24.54% |
| Q1 2022 | -127.63% |
| Q4 2021 | 509.70% |
| Q3 2021 | 54.75% |
| Q2 2021 | -102.16% |
| Q1 2021 | 25.34% |
| Q4 2020 | -4.59% |
| Q3 2020 | 32.28% |
| Q2 2020 | -10.38% |
| Q1 2020 | -75.29% |
| Q4 2019 | -7.58% |
| Q3 2019 | 10.80% |
| Q2 2019 | -6.39% |
| Q1 2019 | 0.03% |
| Q4 2018 | -31.17% |
| Q3 2018 | 24.46% |
| Q2 2018 | -19.69% |
| Q1 2018 | 48.98% |
| Q4 2017 | -13.43% |
| Q3 2017 | 22.82% |
| Q2 2017 | -25.27% |
| Q1 2017 | -63.87% |
| Q4 2016 | 8.31% |
| Q3 2016 | 43.83% |
| Q2 2016 | 17.82% |
| Q1 2016 | -51.27% |